Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

NCCN Task Force report: optimizing treatment of advanced renal cell carcinoma with molecular targeted therapy.

NCCN Task Force report: optimizing treatment of advanced renal cell carcinoma with molecular targeted therapy. J Natl Compr Canc Netw. 2011 Feb; 9 Suppl 1:S1-29.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.